BidaskClub upgraded shares of Cutera, Inc. (NASDAQ:CUTR) from a buy rating to a strong-buy rating in a research note published on Wednesday morning.

A number of other brokerages have also recently weighed in on CUTR. Sidoti reissued a buy rating and set a $32.00 price target (up from $30.00) on shares of Cutera in a research report on Friday, July 7th. Zacks Investment Research cut shares of Cutera from a buy rating to a hold rating in a research report on Monday, June 26th. Roth Capital began coverage on shares of Cutera in a research report on Monday, June 26th. They set a buy rating and a $32.00 price target on the stock. Finally, TheStreet cut shares of Cutera from a b- rating to a c rating in a research report on Monday, May 1st. Four research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of Buy and a consensus target price of $31.50.

Shares of Cutera (NASDAQ CUTR) opened at 27.00 on Wednesday. Cutera has a 12 month low of $10.43 and a 12 month high of $29.25. The firm has a market cap of $374.17 million, a P/E ratio of 103.45 and a beta of 0.60. The stock’s 50 day moving average price is $23.01 and its 200-day moving average price is $20.36.

Cutera (NASDAQ:CUTR) last announced its quarterly earnings results on Monday, May 1st. The medical device company reported ($0.07) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.07). The company had revenue of $29.30 million for the quarter, compared to analysts’ expectations of $29 million. Cutera had a net margin of 2.89% and a return on equity of 9.21%. The business’s quarterly revenue was up 30.8% compared to the same quarter last year. During the same period last year, the firm posted ($0.16) earnings per share. Equities research analysts anticipate that Cutera will post $0.46 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Cutera, Inc. (NASDAQ:CUTR) Upgraded to “Strong-Buy” at BidaskClub” was first published by Daily Political and is owned by of Daily Political. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/07/17/cutera-inc-nasdaqcutr-upgraded-to-strong-buy-at-bidaskclub.html.

In related news, CFO Ronald J. Santilli sold 20,856 shares of the business’s stock in a transaction on Tuesday, May 9th. The shares were sold at an average price of $19.90, for a total value of $415,034.40. Following the sale, the chief financial officer now directly owns 92,178 shares of the company’s stock, valued at approximately $1,834,342.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Ronald J. Santilli sold 60,991 shares of the business’s stock in a transaction on Monday, May 8th. The shares were sold at an average price of $19.99, for a total transaction of $1,219,210.09. Following the completion of the sale, the chief financial officer now directly owns 174,025 shares in the company, valued at $3,478,759.75. The disclosure for this sale can be found here. Insiders sold a total of 160,410 shares of company stock worth $3,410,284 over the last ninety days. 3.30% of the stock is currently owned by insiders.

Large investors have recently bought and sold shares of the stock. American International Group Inc. boosted its stake in Cutera by 7.0% in the first quarter. American International Group Inc. now owns 7,221 shares of the medical device company’s stock valued at $149,000 after buying an additional 475 shares in the last quarter. Metropolitan Life Insurance Co. NY bought a new stake in Cutera during the first quarter valued at approximately $202,000. Federated Investors Inc. PA boosted its stake in Cutera by 143.7% in the fourth quarter. Federated Investors Inc. PA now owns 12,568 shares of the medical device company’s stock valued at $218,000 after buying an additional 7,410 shares in the last quarter. Trexquant Investment LP bought a new stake in Cutera during the first quarter valued at approximately $267,000. Finally, Russell Investments Group Ltd. bought a new stake in Cutera during the fourth quarter valued at approximately $321,000. 81.42% of the stock is currently owned by institutional investors and hedge funds.

Cutera Company Profile

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.